Impact of new regimens and drugs on rifampin-resistant tuberculosis management in Mexico

Muñoz-Torrico1, Marcela; Laniado-Laborín2, Rafael; Rojas-Serrano3, Jorge; Becerril-Vargas4, Eduardo; Cinecio-Chávez2, Wendy; Luna-López5, Fátima Leticia; Narvaez-Díaz4, Luis Armando; Rentería-Gamez2, Roberto; Pilar4, Mariela Segura del; Saavedra5, Nallely; Magaña5, Julio César; D’Ambrosio6, Lia; Centis7, Rosella; Caminero8,9, José Antonio; Migliori7, Giovanni Battista

138
Views

Back to summary

Open Access

Peer-Reviewed
Original Article

Impact of new regimens and drugs on rifampin-resistant tuberculosis management in Mexico

Marcela Muñoz-Torrico1, Rafael Laniado-Laborín2, Jorge Rojas-Serrano3, Eduardo Becerril-Vargas4, Wendy Cinecio-Chávez2, Fátima Leticia Luna-López5, Luis Armando Narvaez-Díaz4, Roberto Rentería-Gamez2, Mariela Segura del Pilar4, Nallely Saavedra5, Julio César Magaña5, Lia D’Ambrosio6, Rosella Centis7, José Antonio Caminero8,9, Giovanni Battista Migliori7

How to cite this article

Muñoz-Torrico1 M, Laniado-Laborín2 R, Rojas-Serrano3 J, Becerril-Vargas4 E, Cinecio-Chávez2 W, Luna-López5 FL, et al. Impact of new regimens and drugs on rifampin-resistant tuberculosis management in Mexico. J Bras Pneumol. 2025;51(5):e20250131